Skip to content

Clinical trials

Active, not recruiting Leukemia, Lymphocytic, Chronic, B-Cell trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Status: Active, not recruiting Country / region: China Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20172
20192
20202
20214
20223
20233
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BeOne Medicines3
Loxo Oncology, Inc.3
AstraZeneca2
BeiGene2
Janssen Research & Development, LLC2
Merck Sharp & Dohme LLC2
AbbVie1
Acerta Pharma BV1
Ascentage Pharma Group Inc.1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell21
Lymphoma, Non-Hodgkin6
Lymphoma, B-Cell4
Hematologic Diseases3
Leukemia3
Lymphoma, Mantle-Cell3
Lymphoma2
Lymphoma, Follicular2
Bronchiolitis Obliterans Syndrome1
Hematologic Neoplasms1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.